Acumen Pharmaceuticals share price logo

Acumen Pharmaceuticals

NASDAQ: ABOS

$2.60

-0.05

(-2.08%)

as on

Acumen Pharmaceuticals Stock Performance

as on September 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.56
    $2.65
    downward going graph

    1.54%

    Downside

    1.92%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.22
    $3.60
    downward going graph

    53.08%

    Downside

    38.46%

    Upside

    downward going graph

Acumen Pharmaceuticals share price movements today

Previous Close
$2.65
Open
$2.61
Volume
922.8K
Market Cap
$191.6M
Day's Low - High
$2.56 - $2.65
52 Week Low - High
$1.22 - $3.60

Acumen Pharmaceuticals Historical Returns

1 Month Return
-16.14 %
3 Month Return
+ 17.26 %
1 Year Return
+ 110.32 %
3 Year Return
-43.97 %
5 Year Return
-82.38 %

Acumen Pharmaceuticals Stock Fundamentals & Key Indicators

Check Acumen Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$191.6M

EPS (TTM)

-1.64

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.76

Industry PE ratio

-2.34

PEG Ratio

-0.05039511520177839

EBITDA

-100.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-136.27%

Acumen Pharmaceuticals Stock Valuation

Track how Acumen Pharmaceuticals P/E has moved over time to understand its valuation trends.

Acumen Pharmaceuticals in the last 5 years

  • Overview

  • Trends

Lowest (-5.12x)

December 31, 2022

Industry (-2.34x)

December 31, 2025

Today (-1.05x)

December 31, 2025

Highest (-1.01x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.05x

Acumen Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Acumen Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$191.6M-82.38%-1.760.00%0.00%
Neutral$61.5B-64.51%-19.3-12.57%0.00%
StrongBuy$130.1B174.21%29.8186.04%0.00%
Buy$80.8B21.32%18.4884.86%0.47%

Stock Returns calculator for Acumen Pharmaceuticals Stock including INR - Dollar returns

The Acumen Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Acumen Pharmaceuticals investment value today

Current value as on today

₹2,23,880

Returns

₹1,23,880

(+123.88%)

Returns from Acumen Pharmaceuticals Stock

₹1,06,349 (+106.35%)

Dollar Impact

₹17,531 (+17.53%)

Analyst Recommendation on Acumen Pharmaceuticals Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Acumen Pharmaceuticals. Average target price of $7.6

Acumen Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Acumen Pharmaceuticals.

What analysts predicted

65.79%UPSIDE

Target Price

$7.6

Current Price

$2.6

Analyzed by

3 Analysts

Target

$7.60

Acumen Pharmaceuticals target price $7.6, a slight upside of 65.79% compared to current price of $2.6. According to 3 analysts rating.

Indian Investors' Interest in Acumen Pharmaceuticals Stock

Search interest for Acumen Pharmaceuticals Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-6% versus previous 30 day period

Acumen Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
0
-
-
-
-
0
-
Operating Income
-17
-24
-32
-39
-30
-41
-26
-25
-21
-32
EBITDA
-13
-19
-28
-36
-27
-39
-25
-24
-19
-31
Interest Expense
1
1
1
1
1
1
1
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-20
-29
-37
-28
-40
-26
-25
-20
-32
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-14
-20
-29
-37
-28
-40
-26
-25
-20
-32
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Acumen Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
1
-
-
-
-
-
Gross Profit
-6
-6
-12
0
-
-
-
Operating Income
-7
-7
-19
-45
-61
-114
-123
EBITDA
-
-7
-100
-42
-51
-98
-116
Interest Expense
-
-
-
-
0
4
4
Depreciation
7
-
0
0
0
0
0
Income Before Tax
-7
-7
-100
-42
-52
-102
-121
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-7
-7
-100
-42
-52
-102
-121
Net Profit Margin
-405.36%
-456.89%
0.00%
0.00%
0.00%
0.00%
0.00%

Acumen Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-14
-20
-29
-37
-28
-40
-26
-25
-20
-32
Operating Cash Flow
-17
-16
-24
-27
-34
-31
-30
-19
-24
-18
Investing Cash Flow
-9
37
-10
29
28
38
40
26
-13
26
Financing Cash Flow
7
0
0
0
0
-
-
0
35
0
Change in Cash
-19
21
-34
2
-5
6
10
7
-2
7

Acumen Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-7
-100
-42
-52
-102
-121
Operating Cash Flow
-6
-7
-17
-35
-43
-86
-115
Investing Cash Flow
-
-
-104
39
-171
48
133
Financing Cash Flow
6
44
200
3
151
6
0
Change in Cash
0
37
78
7
-62
-31
18

Mutual Funds that own Acumen Pharmaceuticals Stock

Check out the Mutual Funds with significant holdings in Acumen Pharmaceuticals.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.038899%
1474477
Fidelity Select Portfolios
1.576386%
1140000
Franklin Strategic Series
1.142742%
826400
Fidelity Concord Street Trust
0.477522%
345331
Bridgeway Funds, Inc.
0.225217%
162871

Global Institutional Holdings in Acumen Pharmaceuticals

Funds
Holdings
Peter Kolchinsky
29.03%
Vanguard
2.7%
iShares
2.24%
Dimensional
0.24%
Bridgeway
0.12%

Insights on Acumen Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ABOS stock has moved up by 110.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 400.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 53.7% return, outperforming this stock by 97.7%

About Acumen Pharmaceuticals

Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. The firm was established in 1996 and maintains its principal headquarters in Charlottesville, Virginia.
OrganisationAcumen Pharmaceuticals
Headquarters1210-1220 Washington St., Newton, MA, 02465, US
IndustryBiotechnology
CEODaniel J. O'Connell
E-voting on sharesClick here to vote

Key Management of Acumen Pharmaceuticals

Name

Title

Dr. James Doherty Ph.D.

President & Chief Development Officer

Mr. Russell Barton M.S.

Chief Operating Officer

Ms. Alex Braun M.B.A.

VP & Head of Investor Relations

Dr. William L. Klein Ph.D.

Co-Founder

Ms. Kelly Carranza

Senior Vice President of Finance & Accounting and Corporate Controller

Mr. Derek M. Meisner Esq., J.D.

Chief Legal Officer & Corporate Secretary

Mr. Daniel J. O'Connell M.B.A.

CEO & Director

Mr. Matt Zuga

CFO & Chief Business Officer

Dr. Grant A. Krafft Ph.D.

Co-Founder

Dr. Caleb E. Finch Ph.D.

Co-Founder

FAQs

What is Acumen Pharmaceuticals share price today?

Acumen Pharmaceuticals share price today is $2.60 as on at the close of the market. Acumen Pharmaceuticals share today touched a day high of $2.65 and a low of $2.56.

What is the 52 week high and 52 week low for Acumen Pharmaceuticals share?

Acumen Pharmaceuticals share touched a 52 week high of $3.60 on and a 52 week low of $1.22 on . Acumen Pharmaceuticals stock price today i.e. is closed at $2.60,which is 27.78% down from its 52 week high and 113.11% up from its 52 week low.

What is Acumen Pharmaceuticals's market capitalisation today?

Acumen Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Acumen Pharmaceuticals Stock (ABOS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Acumen Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Acumen Pharmaceuticals Shares that will get you 0.5769 shares as per Acumen Pharmaceuticals share price of $2.60 per share as on September 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Acumen Pharmaceuticals Stock (ABOS) from India?

Indian investors can start investing in Acumen Pharmaceuticals (ABOS) shares with as little as ₹95.805 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.05 in Acumen Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Acumen Pharmaceuticals share’s latest price of $2.60 as on September 22, 2026 at 1:29 am IST, you will get 3.8462 shares of Acumen Pharmaceuticals. Learn more about fractional shares .

What are the returns that Acumen Pharmaceuticals has given to Indian investors in the last 5 years?

Acumen Pharmaceuticals stock has given -82.38% share price returns and 30.09% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?